Isolatea | MIC (μg/ml)b | ||||||||
---|---|---|---|---|---|---|---|---|---|
AMK | GEN | KAN | TOB | AZM | MEM | CAZ | SXT | CIP | |
Clinical CF | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 C8395 (3/11/1998, Bv1) | 2 | 4 | 2 | 2 | 32 | 1 | 4 | 2/10 | 1 |
 D0774 (25/7/2003, Bv1) | >128 | 128 | 128 | 128 | >2048 | 128 | 128 | 64/320 | >32 |
 D0072 (15/03/2002, Bv3) | 2 | 4 | 1 | 2 | 32 | 0.5 | 2 | 2/10 | 1 |
 D2910 (31/03/2008, Bv3) | 128 | 32 | 64 | 32 | >32 | 2 | 4 | 1/5 | 16 |
In vitro exposed | Â | Â | Â | Â | Â | Â | Â | Â | Â |
 C8395TE (TOB) | >128 | >128 | 128 | >128 | 64 | 1 | 4 | 4/20 | 4 |
 C8395AE (AZM) | 32 | 16 | 16 | 16 | 2048 | 2 | 16 | 8/40 | 4 |
 C8395ME (MEM) | 16 | 8 | 8 | 8 | 32 | 16 | 64 | 4/20 | 16 |
 C8395CE (CAZ) | 8 | 8 | 4 | 4 | 32 | 8 | 16 | 2/10 | 16 |
 C8395SE (SXT) | 8 | 8 | 2 | 2 | 32 | 0.5 | 4 | >64/320 | 8 |
 C8395PE (peroxide) | 32 | 64 | 32 | 32 | 32 | 4 | 16 | 4/20 | 4 |
 C8395PC (control) | 8 | 8 | 4 | 8 | 32 | 1 | 4 | 1/5 | 1 |
 D0072TE (TOB) | 32 | 32 | 16 | 16 | >32 | 1 | 2 | 2/10 | 1 |